Galecto Inc. (GLTO): Price and Financial Metrics


Galecto Inc. (GLTO): $1.32

0.02 (+1.54%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add GLTO to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

GLTO Stock Price Chart Interactive Chart >

Price chart for GLTO

GLTO Price/Volume Stats

Current price $1.32 52-week high $16.41
Prev. close $1.30 52-week low $1.17
Day low $1.29 Volume 53,300
Day high $1.33 Avg. volume 72,858
50-day MA $1.93 Dividend yield N/A
200-day MA $2.77 Market Cap 33.35M

Galecto Inc. (GLTO) Company Bio


Galecto, Inc. operates as a clinical-stage biotechnology company developing therapeutics which are designed to target the biological processes to treat fibrotic and related diseases including cancer. Its product portfolio includes GB0139, GB1211, GB2064, and GB1211. The company was founded by Ulf Nilsson, Hakon Leffler, Tariq Sethi, and Hans T. Schambye in 2011 and is headquartered in Copenhagen, Denmark.


GLTO Latest News Stream


Event/Time News Detail
Loading, please wait...

GLTO Latest Social Stream


Loading social stream, please wait...

View Full GLTO Social Stream

Latest GLTO News From Around the Web

Below are the latest news stories about Galecto Inc that investors may wish to consider to help them evaluate GLTO as an investment opportunity.

Galecto Reports Financial Results for the Year Ended December 31, 2021

Continued pipeline progress with three potentially first-in-class product candidates Strong cash position with cash runway into 2H 2024 BOSTON, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer, today announced its operating and financial results for the year ended December 31, 2021. “During 2021, we made significant progress with our pipeline as we advanced two additional

Yahoo | February 17, 2022

Galecto to Participate at Upcoming Investor Conferences

BOSTON, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer, today announced that management will be participating virtually at two upcoming conferences. Details for both events are below: SVB Leerink Healthcare ConferenceDate:February 16, 2022Time:8:00 am ETWebcast:Register Here Credit Suisse London Healthcare ConferenceDate:March 1-4, 2022Format:Management will be available

Yahoo | February 7, 2022

Galecto Publishes Results Showing Safety and Efficacy of the GB0139 Inhaled Galectin-3 Inhibitor in Hospitalized COVID-19 Patients on Standard of Care

Results Support Favorable Safety and Tolerability Profile and Target Engagement of GB0139 and Potential for GB0139 in Severe Lung Disease Company Provides Update on GALACTIC-1 Trial BOSTON, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer, today announced the publication of the full results of an investigator-initiated open and randomized trial to evaluate Galecto’s inhale

Yahoo | January 27, 2022

Is Galecto (NASDAQ:GLTO) In A Good Position To Invest In Growth?

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Yahoo | January 24, 2022

Marquette Asset Management, LLC Buys Vanguard Total Bond Market ETF, ARK Next Generation ...

Investment company Marquette Asset Management, LLC (Current Portfolio) buys Vanguard Total Bond Market ETF, ARK Next Generation Internet ETF, TAT Technologies, Avantis International Equity ETF, Dril-Quip Inc, sells Vanguard Short-Term Corporate Bond ETF, Vanguard Total Stock Market ETF, Vanguard FTSE Developed Markets ETF, Concord Acquisition Corp, Astrotech Corp during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Marquette Asset Management, LLC.

Yahoo | January 20, 2022

Read More 'GLTO' Stories Here

GLTO Price Returns

1-mo -20.96%
3-mo -31.61%
6-mo -53.52%
1-year -75.14%
3-year N/A
5-year N/A
YTD -56.44%
2021 -75.78%
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.4633 seconds.